Dr. Roman Zeltser, MD

Dr. Zeltser practices at New Hyde Park Endoscopy in Lake Success, New York.

Dr. Zeltser's NPI, 1780751172, was assigned on November 29, 2006. Dr. Zeltser holds New York license 242449.

Dr. Zeltser's primary practice is New Hyde Park Endoscopy, at 1991 Marcus Avenue, Lake Success, NY 11042. The practice phone is (317) 796-7565.

Dr. Zeltser's primary practice is New Hyde Park Endoscopy in Lake Success, New York. Dr. Zeltser is also affiliated with North Shore University Hospital. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Zeltser to 4 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zeltser practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Zeltser's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Zeltser is licensed in New York.

CMS data shows 736 Medicare services from Dr. Zeltser across 10 procedure codes in 2024, for 403 Medicare patients. Medicare paid $64,607 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 403 Medicare patients who saw Dr. Zeltser in 2024. The largest group is 85 and over, with 121 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 44% are also on Medicaid. Their average risk score is 2.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zeltser's median patient age at 73, with 45% women.

In 2024, Dr. Zeltser wrote 330 Medicare Part D claims for 54 patients. 89% of them were for generic drugs. CMS names the drug for 151 of them, across 8 drugs with 11 or more claims each, at $1,989 in total drug cost. In 2023, CMS named 32 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Zeltser for performance year 2024, reported as part of a group. Dr. Zeltser accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 39 papers to Dr. Zeltser, published from 2012 to 2025. 2022 was the busiest year, with 6. The most frequent topics are Coronary Angiography, Coronary Artery Disease and Cardiovascular Diseases. Dr. Zeltser has published most often in Healthcare (Basel). Dr. Zeltser's most frequent co-authors are Amgad Nihad Makaryus, MD, Ofek Hai, DO and Gisele Wolf-Klein, MD.

CMS Open Payments shows 65 general payments to Dr. Zeltser from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Medtronic, Inc. paid the most, $805.